These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Effects of gene transfer CTLA4-Ig and anti-CD154 monoclonal antibody on the rejection of rat islet xenografts]. Zhang J; Chen GH; Weng JP; Lu MQ; Yang Y; Cai CJ; Xu C; Li H Zhonghua Wai Ke Za Zhi; 2008 Jan; 46(2):136-9. PubMed ID: 18509975 [TBL] [Abstract][Full Text] [Related]
24. Adeno-associated virus type 2 (AAV2) capsid-specific cytotoxic T lymphocytes eliminate only vector-transduced cells coexpressing the AAV2 capsid in vivo. Li C; Hirsch M; Asokan A; Zeithaml B; Ma H; Kafri T; Samulski RJ J Virol; 2007 Jul; 81(14):7540-7. PubMed ID: 17475652 [TBL] [Abstract][Full Text] [Related]
25. Secretion of a TNFR:Fc fusion protein following pulmonary administration of pseudotyped adeno-associated virus vectors. Sandalon Z; Bruckheimer EM; Lustig KH; Rogers LC; Peluso RW; Burstein H J Virol; 2004 Nov; 78(22):12355-65. PubMed ID: 15507622 [TBL] [Abstract][Full Text] [Related]
26. Effect of administration of CTLA4-Ig as protein or cDNA on corneal allograft survival. Comer RM; King WJ; Ardjomand N; Theoharis S; George AJ; Larkin DF Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1095-103. PubMed ID: 11923251 [TBL] [Abstract][Full Text] [Related]
27. Slow AAV2 clearance from the brain of nonhuman primates and anti-capsid immune response. Samaranch L; Hadaczek P; Kells AP; Bringas JR; Stockinger D; San Sebastian W; Macayan M; Samineni S; Pivirotto P; Forsayeth J; Bankiewicz KS Gene Ther; 2016 Apr; 23(4):393-8. PubMed ID: 26510688 [TBL] [Abstract][Full Text] [Related]
28. Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8. Inagaki K; Fuess S; Storm TA; Gibson GA; Mctiernan CF; Kay MA; Nakai H Mol Ther; 2006 Jul; 14(1):45-53. PubMed ID: 16713360 [TBL] [Abstract][Full Text] [Related]
29. Targeting the CD80/CD86 costimulatory pathway with CTLA4-Ig directs microglia toward a repair phenotype and promotes axonal outgrowth. Louveau A; Nerrière-Daguin V; Vanhove B; Naveilhan P; Neunlist M; Nicot A; Boudin H Glia; 2015 Dec; 63(12):2298-312. PubMed ID: 26212105 [TBL] [Abstract][Full Text] [Related]
30. Efficient transduction of vascular endothelial cells with recombinant adeno-associated virus serotype 1 and 5 vectors. Chen S; Kapturczak M; Loiler SA; Zolotukhin S; Glushakova OY; Madsen KM; Samulski RJ; Hauswirth WW; Campbell-Thompson M; Berns KI; Flotte TR; Atkinson MA; Tisher CC; Agarwal A Hum Gene Ther; 2005 Feb; 16(2):235-47. PubMed ID: 15761263 [TBL] [Abstract][Full Text] [Related]
31. Primary T lymphocytes as targets for gene therapy. Hanazono Y; Brown KE; Dunbar CE J Hematother Stem Cell Res; 2000 Oct; 9(5):611-20. PubMed ID: 11091484 [TBL] [Abstract][Full Text] [Related]
32. Transient immunomodulation allows repeated injections of AAV1 and correction of muscular dystrophy in multiple muscles. Lorain S; Gross DA; Goyenvalle A; Danos O; Davoust J; Garcia L Mol Ther; 2008 Mar; 16(3):541-7. PubMed ID: 18180780 [TBL] [Abstract][Full Text] [Related]
34. Two novel adeno-associated viruses from cynomolgus monkey: pseudotyping characterization of capsid protein. Mori S; Wang L; Takeuchi T; Kanda T Virology; 2004 Dec; 330(2):375-83. PubMed ID: 15567432 [TBL] [Abstract][Full Text] [Related]
35. Bortezomib and sirolimus inhibit the chronic active antibody-mediated rejection in experimental renal transplantation in the rat. Vogelbacher R; Meister S; Gückel E; Starke C; Wittmann S; Stief A; Voll R; Daniel C; Hugo C Nephrol Dial Transplant; 2010 Nov; 25(11):3764-73. PubMed ID: 20466656 [TBL] [Abstract][Full Text] [Related]
36. In Vivo Genome Editing Restores Dystrophin Expression and Cardiac Function in Dystrophic Mice. El Refaey M; Xu L; Gao Y; Canan BD; Adesanya TMA; Warner SC; Akagi K; Symer DE; Mohler PJ; Ma J; Janssen PML; Han R Circ Res; 2017 Sep; 121(8):923-929. PubMed ID: 28790199 [TBL] [Abstract][Full Text] [Related]